Newly Passed 21st Century Cures Act Increases Research Funding, Will Establish Task Force to Address Gaps Regarding Safe and Effective Therapies for Pregnant and Lactating Women

On Wednesday, December 7, 2016, Congress passed landmark legislation, the 21st Century Cures Acts, substantially increasing funding for biomedical research. Highlights (although actual appropriations are still required and may vary annually) include:

  • $4.796 billion for funding for FY2017-2020 for the National Institutes of Health
  • $1 billion in state grants over the next two years to address opioid abuse and addiction
  • $500 million of funding for FY 2018-2026 for the US Food and Drug Administration
  • $30 million for regenerative medicine research using adult stem cells FY 2017–2020
  • Creation of an interagency task force to identify and address gaps in knowledge and research regarding safe and effective therapies for pregnant women and lactating women, including the development of such therapies and the collaboration on and coordination of such activities.  Within two years, the task force would develop a report to Congress with specific recommendations for addressing the issues identified. 

Also see: Kaiser Health News Grab Bag Of Goodies In 21st Century Cures Act

Recent Stories
PODCAST: Secrets of the Human Brain Revealed: Development, Disease & the Zika Virus

FASEB Report: Reforming Animal Research Regulations: Workshop Recommendations to Reduce Regulatory Burden

NIH Funding Opportunity: The Role of the Microbiome in the Developmental Origins of Health and Disease